A botanical remedy from Brazilian traditional medicine holds promise for aiding individuals suffering from arthritis and various inflammatory disorders. Scientists evaluated Joseph's Coat (Alternanthera littoralis) through laboratory experiments and discovered it lessened inflammation, shielded joint tissues, and proved secure at the administered quantities.
Naturally thriving along Brazil's coastline, Joseph's Coat has long been employed by indigenous groups to alleviate inflammation, infections, and parasitic issues. Previously, concrete scientific proof of its efficacy or safety remained absent.
Collaborative teams from multiple Brazilian institutions, such as the Federal University of Grande Dourados, the State University of Campinas, and São Paulo State University, executed the recent investigation. Their discoveries appeared in the Journal of Ethnopharmacology.
Initially, experts analyzed the chemical components in the aerial portions of the plant's stems and leaves. They formulated an ethanolic extract by employing alcohol to isolate the plant's potent substances.
Within laboratory simulations of arthritis, this extract diminished observable swelling.
"In the experimental setups, we noted decreased edema, enhanced joint metrics, and regulation of inflammatory agents, indicating antioxidant and tissue-preserving properties," stated Arielle Cristina Arena, an associate professor in the Department of Structural and Functional Biology at the Institute of Biosciences at UNESP’s Botucatu Campus, during a press announcement.
Furthermore, it modulated pathways related to inflammation and indicators of oxidative stress, which can harm tissues in prolonged inflammatory states.
Joints treated with the extract exhibited reduced degeneration markers and superior overall condition compared to untreated controls.
The investigative group also performed toxicology assessments to evaluate safety. At the evaluated levels, the plant extract failed to induce adverse reactions in the lab animals, pointing to a favorable safety outlook.


